Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Classifica tra le azioni #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Prezzo delle azioni
$0.78611575
Capitalizzazione di mercato
$60.45M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-12.06%
Paese
NO
Scambia Lytix Biopharma AS (LYTIX)

Categoria

Storico del prezzo dell'azione per Lytix Biopharma AS (LYTIX)
Prezzo di chiusura più alto: $0.83 il 2026-08-01

Prezzo di chiusura più basso: $1.84 il 2021-06-01
Storico del prezzo dell'azione di Lytix Biopharma AS dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.26 37.69%
US
$1.04K 57.37%
NL
$145.66 455.53%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH